Subscribe

login / sign up

close and back to page

Latest News

Latest News

Flexibility at Novartis: Deepti Mitta

Mittal shares how flexible working helped her and her family get through a difficult time.

Originally Published by Novartis.

The "Flexibility at Novartis" series spotlights associates who have one thing in common: They work flexibly. As a result, they are able to manage the demands of their work and private lives. Flexible working can boost employee engagement while increasing efficiency and productivity. This series provides a glimpse into flexible working at Novartis.


Deepti Mittal serves as a Senior Finance Manager within Novartis Business Services in Hyderabad, India. She shares her story below.

Owning the way I work

For me, my job is not just a 9-to-5 job – it is more than that. And the flexibility I have at Novartis gives me an even stronger sense of ownership for my work.

That sense extends to my family. They know that I want and I need to deliver in my job. So, they understand when, for example, I need to work in the evening.

Being there for my family is very important for me as well. In 2012, my daughter – who lives with her grandparents in Delhi – was diagnosed with a medical condition with unclear line of treatment. My whole world was shaken up.

Back then, in Hyderabad, Novartis had a much smaller organization with no formal flexible work policies yet. As part of a lean team, I had people really counting on me. I told my boss I might have to stop working because I wanted to be there for my daughter, and he said, "Wait." He and the team agreed to a temporary flexible work arrangement. For the next few months, I was able to work from home whenever my presence at the office wasn't needed and spent part of the time in another city.

Even before formal flexible work policies were in place, I received the accommodation and emotional support at work that I needed during a difficult time. I'm happy to say my daughter, 11, is doing well now.

Today associates in India generally understand what flexible working means. But our perceptions and culture need to fully catch up. Some people still seem more confident I'll deliver if they can see me at my desk.

I value flexibility not only because I have benefited from it personally but also because it allows me to hire and keep the best people, regardless of their personal situation. Most importantly, it allows people to own the way they work.

What does flexibility at work mean to you?

For me, flexibility means that associates can work when it's most convenient for them as well as for the business.

The Conversation

Novartis: Bringing Real Change to People

An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.

Originally Published by Novartis.

By Goran Mijuk

Since 2012, Thierry Diagana has served as Head of the Novartis Institute for Tropical Diseases (NITD), a small-molecule drug discovery research institute within the Novartis Institutes for BioMedical Research. In this role, he is focused on discovering new medicines that contribute to the elimination of infectious diseases like malaria. He described his team's progress during a recent conversation about NITD and its future.

Read More Show Less

Novartis: Breaking Through Barriers

Finding a virus that crosses the blood-brain barrier could change how some neurological diseases are treated.

Originally Published by Novartis.

By Goran Mijuk

Brian Kaspar speaks with a soft but determined voice, choosing every word carefully.

The 45-year-old researcher, who serves as chief scientific officer of US-based gene therapy company AveXis, is extremely focused. This has helped him in his pursuit to develop gene therapy for patients suffering from deadly motor neuron diseases.

Read More Show Less

Novartis: Artificial Intelligence Decodes Cancer Pathology Images

Novartis researchers are collaborating with tech startup PathAI to search for hidden information in pathology slides.

Originally Published by Novartis.

For 150 years, pathologists have been looking through microscopes at tissue samples mounted on slides to diagnose cancer. Each assessment is weighty: Does this patient have cancer or not?

Read More Show Less

Novartis: The Importance of Caregivers

Melanoma survivor T.J. Sharpe discusses his personal experience with cancer and the important role caregivers play in a patient's road to recovery.

Originally Published by Novartis.

By T.J. Sharpe

Behind every cancer patient, there is likely a caregiver whose critical role is often overlooked. By helping patients understand and process their disease, caregivers can positively impact patients' treatment decisions as well as their ability to adjust to the new reality of being under an oncologist's care.

Read More Show Less

Novartis Announces Clinical Collaboration with Pfizer to Advance the Treatment of NASH

There are currently no approved treatments for NASH, a progressive form of non-alcoholic fatty liver disease, which affects up to 6.5% of the population worldwide.

Originally Published by Novartis.

Novartis announced that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compounds for the treatment of NASH, including an Acetyl CoA-Carboxylase (ACC) Inhibitor (PF-05221304, a Diacylglycerol O-Acyltransferase 2 (DGAT2) Inhibitor (PF-06865571, and a Ketohexokinase (KHK) Inhibitor (PF-06835919). The financial details of this transaction are not disclosed.

Read More Show Less

Novartis: Alcon to Develop SMART Suite Digital Health Platform for Cataract Surgery

As an open, secure cloud-enabled ecosystem, SMART Suite by Alcon will bring greater efficiency to the cataract surgical process and help optimize outcomes for patients.

Originally Published by Novartis.

Alcon, the global leader in eye care and a division of Novartis, announced plans to develop the SMART Suite by Alcon, an innovative, digital platform that is designed to streamline, simplify and improve cataract surgery for surgeons and patients.

Read More Show Less